Javascript must be enabled to continue!
WT1 splice isoforms configure lineage bias during formative pluripotency
View through CrossRef
ABSTRACT
When and how lineage competence first emerges in the epiblast remains a central question in mammalian development. During the transition from naïve to formative pluripotency, epiblast cells acquire responsiveness to lineage-inducing cues, yet whether transcriptional heterogeneity in this window reflects a regulated programme of lineage emergence or stochastic variation, and which molecular regulators shape developmental competence and potential lineage biases, remain poorly defined. Here, using a targeted CRISPRa screen, we identify the developmental regulator Wilms tumor 1 (WT1) as an unexpectedly early regulator of formative pluripotency. WT1 is transiently induced during the transition to formative pluripotency
in vitro
and
in vivo
, with peak expression coinciding with the emergence of lineage-associated transcriptional biases. Precocious Wt1 induction overrides the naïve transcriptional network and advances cells toward a post-implantation epiblast identity, even under naïve-stabilizing conditions. Genome-wide binding analyses show that WT1 engages active regulatory elements of the emerging post-implantation gene regulatory network together with core formative transcription factors, including
Otx2
and
Oct4
. Alternative WT1 splice isoforms encode distinct lineage-biased transcriptional programmes associated with anterior and posterior fates. In the E5.5 epiblast, WT1 expression and splice composition align with lineage-biased transcriptional states, linking isoform usage to anterior–posterior transcriptional tendencies
in vivo
. Isoform-dependent gene expression modules are conserved in human pluripotent cells, indicating that this regulatory logic is preserved across species. Together, our findings indicate that lineage-associated transcriptional programmes begin to diversify during formative pluripotency and identify WT1 as an isoform-tuned regulator that biases these transcriptional outputs.
Title: WT1 splice isoforms configure lineage bias during formative pluripotency
Description:
ABSTRACT
When and how lineage competence first emerges in the epiblast remains a central question in mammalian development.
During the transition from naïve to formative pluripotency, epiblast cells acquire responsiveness to lineage-inducing cues, yet whether transcriptional heterogeneity in this window reflects a regulated programme of lineage emergence or stochastic variation, and which molecular regulators shape developmental competence and potential lineage biases, remain poorly defined.
Here, using a targeted CRISPRa screen, we identify the developmental regulator Wilms tumor 1 (WT1) as an unexpectedly early regulator of formative pluripotency.
WT1 is transiently induced during the transition to formative pluripotency
in vitro
and
in vivo
, with peak expression coinciding with the emergence of lineage-associated transcriptional biases.
Precocious Wt1 induction overrides the naïve transcriptional network and advances cells toward a post-implantation epiblast identity, even under naïve-stabilizing conditions.
Genome-wide binding analyses show that WT1 engages active regulatory elements of the emerging post-implantation gene regulatory network together with core formative transcription factors, including
Otx2
and
Oct4
.
Alternative WT1 splice isoforms encode distinct lineage-biased transcriptional programmes associated with anterior and posterior fates.
In the E5.
5 epiblast, WT1 expression and splice composition align with lineage-biased transcriptional states, linking isoform usage to anterior–posterior transcriptional tendencies
in vivo
.
Isoform-dependent gene expression modules are conserved in human pluripotent cells, indicating that this regulatory logic is preserved across species.
Together, our findings indicate that lineage-associated transcriptional programmes begin to diversify during formative pluripotency and identify WT1 as an isoform-tuned regulator that biases these transcriptional outputs.
Related Results
Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer
Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer
Abstract
Background: WT1 was originally identified in Wilms tumor, a childhood kidney cancer. This gene was expressed in wide variety of solid cancers. Alternative ...
The Role of Wilms’ Tumor Gene (WT1) Peptide-Specific Cytotoxic-T Lymphocytes in Selection of a Paroxysmal Nocturnal Hemoglobinuria (PNH) Clone.
The Role of Wilms’ Tumor Gene (WT1) Peptide-Specific Cytotoxic-T Lymphocytes in Selection of a Paroxysmal Nocturnal Hemoglobinuria (PNH) Clone.
Abstract
It is known that the expression of WT1 increases in leukemic cells from patients with acute and chronic leukemia, and that in leukemic patients, the WT1 eli...
Abstract 1237: WT1, Wnt signaling and E-cadherin in prostate cancer
Abstract 1237: WT1, Wnt signaling and E-cadherin in prostate cancer
Abstract
Prostate carcinoma is the most common malignancy and second leading cause of death among American men. The molecular mechanisms that control the progression...
The Roles of Wilms’ Tumor Gene Peptide-Specific Cytotoxic T Lymphocytes in Immunologic Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria.
The Roles of Wilms’ Tumor Gene Peptide-Specific Cytotoxic T Lymphocytes in Immunologic Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria.
Abstract
It is unclear how a paroxysmal nocturnal hemoglobinuria (PNH) clone expands and bone marrow failure (BMF) occurs in PNH patients, although an immunologic me...
Truncated WT1 protein isoform expression is increased in MCF-7 cells in a long-term estrogen depletion
Truncated WT1 protein isoform expression is increased in MCF-7 cells in a long-term estrogen depletion
Abstract
Background
The WT1 gene codes for a transcription factor that presents several protein isoforms with diverse biologica...
The strength of the HIV-1 3' splice sites affects Rev function
The strength of the HIV-1 3' splice sites affects Rev function
Abstract
Background
The HIV-1 Rev protein is a key component in the early to late switch in HIV-1 splicing from early intronless (e.g. tat, rev) ...
Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child‐specific reference values
Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child‐specific reference values
AbstractBackgroundMeasurable/minimal residual disease (MRD) monitoring can predict imminent hematological relapse in acute myeloid leukemia (AML). The majority of childhood AML pat...
The Wilms' tumor suppressor WT1 regulates Interleukin‐10 expression in macrophagocytic cells
The Wilms' tumor suppressor WT1 regulates Interleukin‐10 expression in macrophagocytic cells
The Wilms' tumor gene, WT1, encodes a zinc finger transcription factor which functions both as a tumor suppressor and a key regulator of embryonic development. WT1 is also expresse...

